Top Markets
#1 PulseChain PulseChain +45.01%
#2 RedStone RedStone +18.29%
#3 Bitway Bitway +12.19%
#4 SkyAI SkyAI +10.14%
#5 Glidr Glidr +9.69%
#6 OPENLOOT OPENLOOT +8.58%
#7 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.71%
#8 Unit Pump Unit Pump +7.24%
#9 Pump.fun Pump.fun +7.24%
#10 Tornado Cash Tornado Cash +7.07%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
TCI GENE Inc. TCI GENE Inc.

TCI GENE Inc.

6879
Rank in Stocks #28088
TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized... TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized preventative healthcare solutions. The company offers an extensive range of genetic screenings, including tests for nutrient metabolism, weight management, and specific G2 and ACE2 markers. Its diverse product portfolio encompasses dietary supplements, skincare items, anti-aging treatments, products designed to support children's development, and solutions targeting Alzheimer's disease. Additionally, TCI GENE provides specialized serums for DNA typing and offers professional nutrition counseling services.
Share Price
$1.08
Last synced: 2026-08-19
Market Cap
$28.61M
Change (1 day)
0.00%
Change (1 year)
-22.93%
Country
TW
Trade TCI GENE Inc. (6879)

Category

Healthcare
Revenue for TCI GENE Inc. (6879)
Revenue in Aug 2026 TTM: 0
According to TCI GENE Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for TCI GENE Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH